Publications

2015

Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.

2015, 20151201. Nature Cell Biology. 17(12): 1556-68. Epub 2015 Nov 23.

Tardito S, Oudin A, Ahmed SU, Fack F, Keunen O, Zheng L, Miletic H, Sakariassen PO, Weinstock A, Wagner A, Lindsay SL, Hock AK, Barnett SC, Ruppin E, Morkve SH, Lund-Johansen M, Chalmers AJ, Bjerkvig R, Niclou SP, Gottlieb E.

https://www.ncbi.nlm.nih.gov/pubmed/26595383

Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes.

2015, 20151101. FASEB Journal. 29(11): 4695-712. Epub 2015 Jul 28.

Burtey A, Wagner M, Hodneland E, Skaftnesmo KO, Schoelermann J, Mondragon IR, Espedal H, Golebiewska A, Niclou SP, Bjerkvig R, Kogel T, Gerdes HH.

https://www.ncbi.nlm.nih.gov/pubmed/26220176

Correction: Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.

2015, 20151002. PLoS One. 10(10): e0140303.

Huszthy PC, Sakariassen PO, Espedal H, Brokstad KA, Bjerkvig R, Miletic H.

https://www.ncbi.nlm.nih.gov/pubmed/26431334

Melanoma brain metastasis is independent of lactate dehydrogenase A expression.

2015, 20151001. Neuro-Oncology. 17(10): 1374-85. Epub 2015 Mar 19.

Sundstrom T, Espedal H, Harter PN, Fasmer KE, Skaftnesmo KO, Horn S, Hodneland E, Mittelbronn M, Weide B, Beschorner R, Bender B, Rygh CB, Lund-Johansen M, Bjerkvig R, Thorsen F.

https://www.ncbi.nlm.nih.gov/pubmed/25791837

Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.

2015, 20150820. PLoS One. 10(8): e0136089.

Huszthy PC, Sakariassen PO, Espedal H, Brokstad KA, Bjerkvig R, Miletic H.

https://www.ncbi.nlm.nih.gov/pubmed/26291724

The pH sensibility of actin-bundling LIM proteins is governed by the acidic properties of their C-terminal domain.

2015, 20150819. FEBS Letters. 589(18): 2312-9. Epub 2015 Jul 29.

Moes D, Hoffmann C, Dieterle M, Moreau F, Neumann K, Papuga J, Furtado AT, Steinmetz A, Thomas C.

https://www.ncbi.nlm.nih.gov/pubmed/26226417

Gauging heterogeneity in primary versus recurrent glioblastoma.

2015, 20150701. Neuro-Oncology. 17(7): 907-9. Epub 2015 May 12.

Niclou SP.

https://www.ncbi.nlm.nih.gov/pubmed/25972456

Inference of low and high-grade glioma gene regulatory networks delineates the role of Rnd3 in establishing multiple hallmarks of cancer.

2015, 20150701. PLoS Genetics. 11(7): e1005325.

Clarke K, Daubon T, Turan N, Soulet F, Mohd Zahari M, Ryan KR, Durant S, He S, Herbert J, Ankers J, Heath JK, Bjerkvig R, Bicknell R, Hotchin NA, Bikfalvi A, Falciani F.

https://www.ncbi.nlm.nih.gov/pubmed/26132659

Epigenetic activity of peroxisome proliferator-activated receptor gamma agonists increases the anticancer effect of histone deacetylase inhibitors on multiple myeloma cells.

2015, 20150619. PLoS One. 10(6): e0130339.

Aouali N, Broukou A, Bosseler M, Keunen O, Schlesser V, Janji B, Palissot V, Stordeur P, Berchem G.

https://www.ncbi.nlm.nih.gov/pubmed/26091518

Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.

2015, 20150501. PLoS One. 10(5): e0123544.

Sanzey M, Abdul Rahim SA, Oudin A, Dirkse A, Kaoma T, Vallar L, Herold-Mende C, Bjerkvig R, Golebiewska A, Niclou SP.

https://www.ncbi.nlm.nih.gov/pubmed/25932951

OECI-EACR precision medicine for cancer: Conference report 1-4 March 2015, Luxembourg.

2015, 20150403. Ecancermedicalscience. 9: 519.

Golebiewska A, Fritah S, Girotti MR.

https://www.ncbi.nlm.nih.gov/pubmed/25932043

Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.

2015, 20150331. Cell Communication and Signaling. 13(1): 23.

Azuaje F, Tiemann K, Niclou SP.

https://www.ncbi.nlm.nih.gov/pubmed/25885672

Whole genomes redefine the mutational landscape of pancreatic cancer.

2015, 20150225. Nature. 518(7540): 495-501.

Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson MJ, Fink JL, Holmes O, Kazakoff SH, Leonard C, Newell F, Poudel B, Song S, Taylor D, Waddell N, Wood S, Xu Q, Wu J, Pinese M, Cowley MJ, Lee HC, Jones MD, Nagrial AM, Humphris J, Chantrill LA, Chin V, Steinmann AM, Mawson A, Humphrey ES, Colvin EK, Chou A, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Pettitt JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Niclou SP, Bjerkvig R, Grutzmann R, Aust D, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA, Gill AJ, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Pearson JV, Biankin AV, Grimmond SM.

https://www.ncbi.nlm.nih.gov/pubmed/25719666

Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.

2015, 20150122. OncoImmunology. 4(4): e998107.

Du Four S, Maenhout SK, De Pierre K, Renmans D, Niclou SP, Thielemans K, Neyns B, Aerts JL.

https://www.ncbi.nlm.nih.gov/pubmed/26137411

A gene mapping bottleneck in the translational route from zebrafish to human.

2015, 20150112. Frontiers in Genetics. 5: 470.

de Klein N, Ibberson M, Crespo I, Rodius S, Azuaje F.

https://www.ncbi.nlm.nih.gov/pubmed/25628646

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.

2015, 20150101. Acta Neuropathologica. 129(1): 115-31. Epub 2014 Oct 17.

Fack F, Espedal H, Keunen O, Golebiewska A, Obad N, Harter PN, Mittelbronn M, Bahr O, Weyerbrock A, Stuhr L, Miletic H, Sakariassen PO, Stieber D, Rygh CB, Lund-Johansen M, Zheng L, Gottlieb E, Niclou SP, Bjerkvig R.

https://www.ncbi.nlm.nih.gov/pubmed/25322816